Dermtech Stock Current Liabilities
| DMTKDelisted Stock | USD 0.04 0.02 71.36% |
DermTech fundamentals help investors to digest information that contributes to DermTech's financial success or failures. It also enables traders to predict the movement of DermTech Stock. The fundamental analysis module provides a way to measure DermTech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to DermTech stock.
DermTech |
DermTech Company Current Liabilities Analysis
DermTech's Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Current DermTech Current Liabilities | 446.54 K |
Most of DermTech's fundamental indicators, such as Current Liabilities, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, DermTech is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
CompetitionIn accordance with the recently published financial statements, DermTech has a Current Liabilities of 446.54 K. This is 99.97% lower than that of the Biotechnology sector and 99.92% lower than that of the Health Care industry. The current liabilities for all United States stocks is 99.99% higher than that of the company.
DermTech Current Liabilities Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses DermTech's direct or indirect competition against its Current Liabilities to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of DermTech could also be used in its relative valuation, which is a method of valuing DermTech by comparing valuation metrics of similar companies.DermTech is currently under evaluation in current liabilities category among its peers.
DermTech Fundamentals
| Return On Equity | -1.22 | |||
| Return On Asset | -0.39 | |||
| Operating Margin | (5.33) % | |||
| Current Valuation | 15.43 M | |||
| Shares Outstanding | 34.96 M | |||
| Shares Owned By Insiders | 2.62 % | |||
| Shares Owned By Institutions | 18.09 % | |||
| Number Of Shares Shorted | 3.36 M | |||
| Price To Earning | (139.70) X | |||
| Price To Book | 0.02 X | |||
| Price To Sales | 0.21 X | |||
| Revenue | 15.3 M | |||
| Gross Profit | 647 K | |||
| EBITDA | (97.89 M) | |||
| Net Income | (100.89 M) | |||
| Cash And Equivalents | 173.79 M | |||
| Cash Per Share | 5.78 X | |||
| Total Debt | 54.39 M | |||
| Debt To Equity | 0.14 % | |||
| Current Ratio | 12.19 X | |||
| Book Value Per Share | 1.14 X | |||
| Cash Flow From Operations | (76.98 M) | |||
| Short Ratio | 2.64 X | |||
| Earnings Per Share | (2.65) X | |||
| Target Price | 1.5 | |||
| Number Of Employees | 206 | |||
| Beta | 2.42 | |||
| Market Capitalization | 3.29 M | |||
| Total Asset | 121.93 M | |||
| Retained Earnings | (423.94 M) | |||
| Working Capital | 48.3 M | |||
| Current Asset | 140.61 K | |||
| Current Liabilities | 446.54 K | |||
| Net Asset | 121.93 M |
About DermTech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze DermTech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of DermTech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of DermTech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Other Consideration for investing in DermTech Stock
If you are still planning to invest in DermTech check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the DermTech's history and understand the potential risks before investing.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |